Exp Ther Med 19:[Related article:] 696–702, 2020; DOI:
10.3892/etm.2019.8246
Following the publication of this article, a
concerned reader drew to our attention that a pair of the data
panels featured in Fig. 4D featured some striking and unexpected
similarities with data panels in Fig. 2D in an article published at
a similar time [Luo B, Yang J-F, Wang Y-H, Qu G-B, Hao P-D, Zeng
Z-J, Yuan J and Yuan Y: MicroRNA-579-3p promotes the progression of
osteoporosis by inhibiting osteogenic differentiation of
mesenchymal stem cells through regulating Sirt1. Eur Rev Med
Pharmacol Sci 23: 6791-6799, 2019], and Fig. 2E in another article
that was published in 2019 [Fy Y-C, Zhao S-R, Zhu B-H, Guo S-S and
Wang X-X: MiRNA-27a-3p promotes osteogenic differentiation of human
mesenchymal stem cells through targeting ATF3. Eur Rev Med
Pharmacol Sci 23: 73-80, 2019].
After having conducted an internal investigation,
the Editor of Experimental and Therapeutic Medicine agrees
that the data in question had originated from the same original
source(s). Therefore, owing to the fact that the contentious data
in the above article had already been published elsewhere, or were
already under consideration for publication, prior to its
submission to Experimental and Therapeutic Medicine, the
Editor has decided that this paper should be retracted from the
Journal. The authors independently contacted the Editorial Office
to request that the article be retracted on account of an
authorship dispute. The Editor sincerely apologizes to the
readership for the inconvenience caused, and we also thank the
reader for bringing this matter to our attention.
